Stuttgart - Delayed Quote EUR

Biomark Diagnostics Inc (20B.SG)

0.1640
+0.0080
+(5.13%)
At close: May 12 at 9:47:54 PM GMT+2
All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-855.6450
-982.5210
-914.4210
-1,203.9280
-807.3000
Investing Cash Flow
-3.7440
-4.3940
-5.2990
-59.2010
-3.2000
Financing Cash Flow
634.9400
1,071.6270
609.0460
768.1620
1,076.3750
End Cash Position
88.5830
156.7490
72.0370
382.7110
877.6780
Income Tax Paid Supplemental Data
--
--
--
--
0
Interest Paid Supplemental Data
--
62.6640
74.4600
28.9940
0.7850
Capital Expenditure
-3.7440
-4.3940
-5.2990
-59.2010
--
Issuance of Capital Stock
0
1,541.8740
603.1950
0
--
Issuance of Debt
0
0
85
150
100
Repayment of Debt
-604.1450
-732.6420
-384.9860
-310.7820
-11.9880
Free Cash Flow
-859.3890
-986.9150
-919.7200
-1,263.1290
-807.3000
3/31/2021 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade